Abstract
C20H18N4O4, orthorhombic, Pbca (no. 61), a = 7.670(4) Å, b = 15.679(8) Å, c = 29.170(17) Å, V = 3508(3) Å3, Z = 8, Rgt(F) = 0.0497, wRref(F2) = 0.1379, T = 243(2) K.
The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Data collection and handling.
| Crystal: | Yellow block |
| Size: | 0.18 × 0.12 × 0.09 mm |
| Wavelength: | Mo Kα radiation (0.71073 Å) |
| μ: | 0.10 mm−1 |
| Diffractometer, scan mode: | PHOTON III M14, φ and ω |
| θmax, completeness: | 28.3°, >99% |
| N(hkl)measured, N(hkl)unique, Rint: | 74,837, 4372, 0.118 |
| Criterion for Iobs, N(hkl)gt: | Iobs > 2 σ(Iobs), 3673 |
| N(param)refined: | 257 |
| Programs: | Bruker [1], SHELX [2, 3], Olex2 [4] |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
| Atom | x | y | z | Uiso*/Ueq |
|---|---|---|---|---|
| C1 | 0.38484 (18) | 0.59378 (8) | 0.62791 (5) | 0.0257 (3) |
| C2 | 0.35701 (17) | 0.62097 (8) | 0.67182 (5) | 0.0259 (3) |
| H2 | 0.2897 | 0.6702 | 0.6768 | 0.031* |
| C3 | 0.42787 (17) | 0.57634 (8) | 0.71030 (4) | 0.0242 (3) |
| C4 | 0.54978 (19) | 0.47869 (9) | 0.66024 (5) | 0.0289 (3) |
| C5 | 0.6293 (2) | 0.41849 (10) | 0.60014 (6) | 0.0423 (4) |
| H5 | 0.6829 | 0.3785 | 0.5807 | 0.051* |
| C6 | 0.30267 (18) | 0.63133 (9) | 0.58661 (5) | 0.0266 (3) |
| C7 | 0.31347 (18) | 0.71865 (9) | 0.57803 (5) | 0.0268 (3) |
| C8 | 0.22543 (18) | 0.75381 (9) | 0.53996 (5) | 0.0285 (3) |
| C9 | 0.1308 (2) | 0.70083 (10) | 0.51126 (5) | 0.0359 (3) |
| H9 | 0.0719 | 0.7238 | 0.4858 | 0.043* |
| C10 | 0.1226 (2) | 0.61363 (10) | 0.52003 (5) | 0.0382 (4) |
| H10 | 0.0580 | 0.5781 | 0.5004 | 0.046* |
| C11 | 0.2077 (2) | 0.57875 (9) | 0.55698 (5) | 0.0327 (3) |
| H11 | 0.2020 | 0.5197 | 0.5623 | 0.039* |
| C12 | 0.3499 (4) | 0.83560 (11) | 0.62957 (7) | 0.0630 (6) |
| H12A | 0.3261 | 0.8832 | 0.6093 | 0.095* |
| H12B | 0.4310 | 0.8535 | 0.6532 | 0.095* |
| H12C | 0.2421 | 0.8167 | 0.6437 | 0.095* |
| C13 | 0.1568 (3) | 0.87668 (11) | 0.49522 (6) | 0.0429 (4) |
| H13A | 0.1958 | 0.8500 | 0.4670 | 0.064* |
| H13B | 0.1820 | 0.9373 | 0.4941 | 0.064* |
| H13C | 0.0322 | 0.8683 | 0.4987 | 0.064* |
| C14 | 0.40307 (17) | 0.60166 (8) | 0.75868 (4) | 0.0250 (3) |
| C15 | 0.32199 (18) | 0.67928 (9) | 0.77281 (5) | 0.0282 (3) |
| C16 | 0.3013 (2) | 0.69961 (10) | 0.81890 (5) | 0.0374 (3) |
| H16 | 0.2484 | 0.7514 | 0.8273 | 0.045* |
| C17 | 0.3586 (2) | 0.64355 (12) | 0.85240 (5) | 0.0418 (4) |
| H17 | 0.3431 | 0.6574 | 0.8835 | 0.050* |
| C18 | 0.4372 (2) | 0.56849 (11) | 0.84076 (5) | 0.0372 (3) |
| H18 | 0.4743 | 0.5308 | 0.8638 | 0.045* |
| C19 | 0.46275 (19) | 0.54748 (9) | 0.79470 (5) | 0.0298 (3) |
| C20 | 0.1802 (2) | 0.81018 (10) | 0.75238 (6) | 0.0398 (4) |
| H20A | 0.0763 | 0.7959 | 0.7697 | 0.060* |
| H20B | 0.1476 | 0.8421 | 0.7252 | 0.060* |
| H20C | 0.2571 | 0.8446 | 0.7712 | 0.060* |
| N1 | 0.52069 (16) | 0.50528 (7) | 0.70339 (4) | 0.0280 (3) |
| N2 | 0.48650 (16) | 0.52257 (7) | 0.62295 (4) | 0.0276 (3) |
| N3 | 0.54005 (19) | 0.48372 (8) | 0.58320 (4) | 0.0378 (3) |
| N4 | 0.6406 (2) | 0.41137 (8) | 0.64611 (5) | 0.0388 (3) |
| O1 | 0.42467 (16) | 0.76693 (7) | 0.60383 (4) | 0.0388 (3) |
| O2 | 0.24599 (15) | 0.83905 (6) | 0.53345 (4) | 0.0351 (3) |
| O3 | 0.26813 (15) | 0.73349 (6) | 0.73912 (4) | 0.0349 (3) |
| O4 | 0.54735 (16) | 0.47357 (7) | 0.78714 (4) | 0.0390 (3) |
| H4 | 0.5643 | 0.4676 | 0.7592 | 0.059* |
Source of material
To a solution of 2,3-dimethoxybenzaldehyde (10 mmol, 1.66 g) in 40 ml of ethanol was added 1-(2-hydroxy-6-methoxyphenyl)ethanone (10 mmol, 1.66 g) and the reaction mixture was cooled in an ice-bath. To the reaction mixture was added 10 ml of 40% (w/v) aqueous KOH solution and the reaction mixture was stirred at room temperature for 10 h. At the end of the reaction, ice water was added to the mixture and it was acidified with 6 N HCl (pH = 3–4). The resulting precipitate was filtered and washed with water and ethanol. The crude solid was purified by recrystallization from ethanol to give pure chalcone of (E)-3-(2,3-dimethoxyphenyl)-1-(2-hydroxy-6-methoxyphenyl)prop-2-en-1-one (1.92 g, 61%). An excess amount of 1H-1,2,4-triazol-5-amine (0.84 g, 10 mmol) was added to a solution of the chalcone compound (5 mmol, 1.67 g) in 20 ml DMF, and 1 mL of triethylamine was added to the reaction mixture and was refluxed at 393 K for 15 h. The reaction mixture was cooled to room temperature and was acidified with 3N HCl (pH = 3–4). The resulting precipitate was filtered and washed with ethanol. The crude solid was purified by recrystallization from ethanol to afford the title compound.
Experimental details
Data collections and reduction were carried out using the Bruker software APEX2 and SAINT including Sadabs [1]. Hydrogen atoms were placed in their geometrically idealized positions and constrained to ride on their parent atoms with C–H = 0.96 Å (methyl), Uiso(H) = 1.5 Ueq(C), C–H = 0.94 Å (aromatic), Uiso(H) = 1.2 Ueq(C), O–H = 0.83 Å (hydroxyl), Uiso(H) = 1.5 Ueq(O).
Comment
Triazolo pyrimidine is a heterocycle compound in which a triazole ring and pyrimidine ring are fused. According to a recent review, triazolo pyrimidines have been reported to exhibit various physiological activities [5], and are actively used in drug development [6]. Triazolo pyrimidine is synthesized through the Michael addition reaction of 1,2,4-triazol-5-amine with α,β-unsaturated ketones such as chalcone. Depending on the nitrogens of the triazole used in the reaction, different isomers that cannot be identified by NMR are often formed. In this study, the target compound was obtained by the reaction between 1,2,4-triazol-5-amine and chalcone compound (E)-3-(2,3-dimethoxyphenyl)-1-(2-hydroxy-6-methoxyphenyl)prop-2-en-1-one. There is a possibility that two isomers, 2-(7-(2,3-dimethoxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)-3-methoxyphenol and 2-(5-(2,3-dimethoxyphenyl)-[1,2,4]triazolo[4,3-a]pyrimidin-7-yl)-3-methoxyphenol can be synthesized through this reaction. The two possible isomers are too similar to be distinguished by NMR. The structure of the target compound was clearly confirmed to be 2-(7-(2,3-dimethoxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)-3-methoxyphenol through single crystal X-ray analysis.
The molecular structure of the title compound is shown in the Figure. The central triazolo-pyrimidine fragment (C1–C3/N1/C4/N4/C5/N3/N2) connects the two benzene rings (C6–C11 and C14–C19) at carbon atoms 1 and 3, respectively. The dihedral angle formed by the triazolo-pyrimidine fragment and the C6–C11 benzene ring is 52.5(1)°, which indicates that these two fragments are highly twisted with each other. On the other hand, the dihedral angle between the triazolo-pyrimidine fragment and the C14–C19 benzene ring is 6.97(2)°, indicating that these fragments are close to coplanar. The dihedral angle between the benzene rings is 48.9(3)°. There are three methoxy groups, which are attached to carbon-atom C7 and C8 of the first benzene ring and C15 of the second. The C13 and C20 atoms of the methoxy groups at C8 and C15 are nearly co-planar with their corresponding ring plane by torsion angles C9–C8–O2–C13 = 2.8(2)° and C16–C15–O3–C20 = −3.5(2)°, respectively. The C12 atom of the methoxy group at C7 is rotated significantly from the benzene ring with torsion angle C8–C7–O1–C12 = 66.2(2)°. The hydroxyl group forms an intramolecular O4–H4⃛N1 hydrogen bond with the N1 atom (the H⃛N distance is 1.76 Å, the O–H⃛N angle is 147°) of the triazolo-pyrimidine ring. In the crystal, pairs of C12–H12⃛O4 and C20–H20⃛N4 hydrogen bonds link the molecules into chains propagating along the b-axis direction. Three-dimensional structures of triazolo-pyrimidine compounds with similar structures have recently been reported [7, 8].
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Research funding: The Korea Drug Development Fundfunded by Ministry of Science and Information and Communication Technologies (ICT), Ministry of Trade, Industry and Energy, and Ministry of Health and Welfare (award No. HN21C0984), Republic of Korea. S. Y. Shin was supported by the KU Research Professor Program of Konkuk University.
-
Conflict of interest statement: The authors declare no conflicts of interest regarding this article.
References
1. Bruker. SAINT, APEX2 and SADABS; Bruker AXS Inc.: Madison, WI, USA, 2012.Search in Google Scholar
2. Sheldrick, G. M. SHELXT – integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8; https://doi.org/10.1107/s2053273314026370.Search in Google Scholar PubMed PubMed Central
3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar
4. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Search in Google Scholar
5. Yu, G.-X., Hu, Y., Zhang, W.-X., Tian, X.-Y., Zhang, S.-Y., Zhang, Y., Yuan, S., Song, J. Design, synthesis and biological evaluation of [1,2,4]triazolo[1,5-a]pyrimidine indole derivatives against gastric cancer cells MGC-803 via the suppression of ERK signaling pathway. Molecules 2022, 27, 4996; https://doi.org/10.3390/molecules27154996.Search in Google Scholar PubMed PubMed Central
6. Oukoloff, K., Lucero, B., Francisco, K. R., Brunden, K. R., Ballatore, C. 1,2,4-Triazolo[1,5-a]pyrimidines in drug design. Eur. J. Med. Chem. 2019, 165, 332–346; https://doi.org/10.1016/j.ejmech.2019.01.027.Search in Google Scholar PubMed PubMed Central
7. Gilandoust, M., Harsha, K. B., Kumar, M., Rakesh, K. S., Lokanath, N. K., Byrappa, K., Rangappa, K. S. 5-(2-Ethoxy-4-fluorophenyl)-1,2,4-triazolo[1,5-a]-pyrimidine. IUCrData 2016, 1, x161770; https://doi.org/10.1107/s2414314616017703.Search in Google Scholar
8. Lan, W.-J., Liu, C.-Y., Luo, Y.-B., Fei, Q., Wu, W.-N. Crystal structure of 3-((2,4-dichlorobenzyl)thio)-5-methyl-7-(trifluoromethyl)-[1,2,4]triazolo[4,3-c]pyrimidine, C14H9Cl2F3N4S. Z. Kristallogr. N. Cryst. Struct. 2022, 237, 1047–1048; https://doi.org/10.1515/ncrs-2022-0360.Search in Google Scholar
© 2022 the author(s), published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Articles in the same Issue
- Frontmatter
- New Crystal Structures
- The crystal structure of methyl 2-((4-chloro-2-fluoro-6-((2,2,2-trifluoroethyl) thio)phenoxy)methyl)benzoate, C17H13ClF4O3S
- The crystal structure of 3-hydroxy-5-oxo-4-propanoylcyclohex-3-ene-1-carboxylic monohydrate, C10H14O6
- Crystal structure of 2-({[5-(adamantan-2-yl)-2-sulfanylidene-1,3,4-oxadiazolidin-3-yl]methyl}amino)benzonitrile, C20H22N4OS
- Crystal structure of 1-(3-bromopropyl)-2-((4-chlorophenoxy)methyl)-4-methyl-1H-benzo[d]imidazole, C18H18BrClN2O
- Crystal structure of 2-methoxy-6-[(2-morpholin-4-yl-phenylamino)-methylene]-4-nitro-cyclohexa-2,4-dienone, C18H19N3O5
- The crystal structure of 2-(7-(2,3-dimethoxyphenyl)-[1,2,4]triazolo[1,5-a]-pyrimidin-5-yl)-3-methoxyphenol, C20H18N4O4
- The crystal structure of 3-(1-(2-(4-hydroxy-3,5-dimethoxybenzylidene)hydrazinyl)ethylidene)chroman-2,4-dione dihydrate, C20H22N2O8
- Crystal structure of 3,5,7-trimethoxy-3′,4′-methylenedioxy-flavone, C19H16O7
- The crystal structure of strictic acid, C20H26O3
- Crystal structure of 1,1′-(pyrazine-1,4-diyl)-bis(propan-2-one), C10H14N2O2
- The crystal structure of 1-(adamantan-1-yl)-3-(4-chlorophenyl)urea, C17H21ClN2O
- The crystal structure of (2R,6′R)-2′,7-dichloro-4,6-dimethoxy-6′-methyl-3H-spiro[benzofuran-2,1′-cyclohexan]-2′-ene-3,4′-dione, C16H14Cl2O5
- Synthesis and crystal structure of 1-((3R,10S,13R,17S)-3-((4-methoxyphenyl)amino)-10,13-dimethylhexadecahydro-1H-cyclopenta[α]-phenanthren-17-yl)ethan-1-one, C28H41NO2
- Crystal structure of N-2,6-difluorobenzoyl-N′-[1-(3-chloro-4-methyl-phenyl)-4-cyano-1H-pyrazol-5-carbamoyl]urea, C19H12ClF2N5O2
- Crystal structure of (−)-β-D-19-glucopiranosyl-9,15-dihydroxy kaurenoate, C26H40O9
- Crystal structure of 7-hydroxy-6-(2-hydroxyethyl)-2H-chromen-2-one, C11H10O4
- Crystal structure of S-(benzo[d]thiazol-2-yl)-N-(tert-butyl)thiohydroxylamine, C11H14N2S2
- Crystal structure of poly[di-µ2-aqua-aqua-nitrato-κ2O,O′-(µ3-2-nitroisophthalato-κ4O,O′:O″:O′″)barium(II)natrium(II)] monohydrate, C8H11BaN2NaO13
- The crystal structure of diaqua-bis(pyrazolo[1,5-a]pyrimidine-3-carboxylato-κ2 N,O)-cobalt(II) dihydrate, C14H16N6O8Co
- Crystal structure of (S,E)-3-((pyridin-2-ylmethylene)amino)-2-(pyridin-4-yl)-2,3- dihydroquinazolin-4(1H)-one monohydrate, C19H15N5O⋅H2O
- Synthesis and crystal structure of 5-(8-(((5-carboxypentyl)ammonio)methyl)-7-hydroxy-4-oxo-4H-chromen-3-yl)-2-hydroxy-3-nitrobenzenesulfonate monohydrate, C22H24N2O12S
- Synthesis and crystal structure of 8-bromo-3-(1H-pyrazole-1-carbonyl)-2H-chromen-2-one, C13H7BrN2O3
- Crystal structure of E-7-fluoro-2-(4-methoxy-3-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C19H14F4O2
- Hydrogen bonded dimers in the crystal structure of 2-chloro-N-((3,5-dimethylphenyl)carbamoyl)-nicotinamide, C30H28Cl2N6O4
- Crystal structure of 3,3′-(1,4-phenylenebis(methylene))bis(1-allyl-1H-imidazol-3-ium) bis(hexafluoro phosphate)(V), C10H12F6N2P
- Crystal structure of (E)-7-bromo-2-(4-(4-methylpiperazin-1-yl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H23BrN2O
- Crystal structure of pentacarbonyl-(μ2-ethane-1,2-dithiolato-κ4S:S,S′:S′)-(diphenyl(o-tolyl)phosphine-κ1P)diiron (Fe–Fe), C26H21Fe2O5PS2
- Crystal structure of 9-(2-chloroethoxy)-4-(4-methoxy-3-(trifluoromethyl)phenyl)- 5,6-dihydrobenzo[h]quinazolin-2-amine, C22H19ClF3N3O2
- Crystal structure of triaqua-[5-bromo-2-(carboxylatomethoxy)benzoate-κ3 O,O′,O″]nickel(II), C9H11BrNiO8
- The crystal structure of 4,4′-dichloro-3,5′-diphenyl-1′H-1,3′- bipyrazole, C18H12Cl2N4
- The crystal structure of bis(1H-pyrazole-carboxamidine-κN,N′)bis(nitrato-κO)-copper(II), C8H12CuN10O6
- Synthesis and crystal structure of 3-bromo-4-phenyl-2H-chromene, C15H11BrO
- Crystal structure of (E)-5-(diethylamino)-2-((morpholinoimino)methyl)phenol, C15H23N3O2
- Crystal structure of niobium trigallide, NbGa3
- Crystal structure of dimethyl 4,4′-(((1R, 2R)-cyclohexane-1,2-diyl)bis(azanediyl))dibenzoate, C22H26N2O4
- Crystal structure of dimethyl 4,4′-((4R, 5R)-4,5-diphenylimidazolidine-1,3-diyl)dibenzoate, C31H28N2O4
- The crystal structure of 2-(2-bromophenyl)-4-phenylbenzo[b][1,4]oxaphosphinine 4-oxide, C20H14BrO2P
- The crystal structure of 3-hydroxy-2-nitroestra-1,3,5(10)-trien-17-one, C18H21NO4
- Crystal structure of catena-poly[[μ2-1,3-bis[(1H-imidazol-1- yl)methyl]benzene-N:N′]-(μ2–D–camphorato-O, O′: O″, O‴)cadmium(II)], C48H56Cd2N8O8
- Crystal structure of N-(4-bromophenyl)-4-[3-(trifluoromethyl)phenyl]-piperazine-1-carbothioamide, C18H17BrF3N3S
- The crystal structure of cis-Dicyano-bis(2,2′-bipyridine)k2N,N′-chromium(III) hexafluorophosphate, C22H16N6F6PCr
- Crystal structure of 4-((6-bromohexyl)oxy)-2-hydroxybenzaldehyde, C13H17BrO3
- Crystal structure of hydrazinium methanesulfonate, CH8N2O3S
- Crystal structure of 1-(2-iodobenzoyl)-6-methoxy-1H-indole-3-carbaldehyde, C17H12INO3
- Crystal structure of bis(acridinium) tetrabromidomanganate(II), C26H20Br4MnN2
- The crystal structure of 6,6′-((1E,1′E)-hydrazine-1,2-diylidenebis(methanylylidene)) bis(2-(tert-butyl)phenol), C22H28N2O2
- The crystal structure of the cocrystal di-μ2-chlorido-tetramethyl-tetraphenyl-di-μ3-oxido-dichloridotetratin(IV) – diphenyl-methyl-chloridotin(IV)(1/2), C54H58Cl6O2Sn6
- Crystal structure of (3a7R,13bR)-3-((1R)-1-hydroxy-1-(5-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-3a,11,11,13b-tetramethyl-2,3,3a,4,5,11,11a,12,13,13b-decahydroindeno[5′,4′:4,5] cyclohepta[1,2-c]oxepin-9(1H)-one, C30H40O5
- Crystal structure of 1-(4-methoxyphenyl)-2-phenoxyethan-1-one, C15H14O3
- Crystal structure of trans-tetrakis(3-phenylpyridine-κN)bis(thiocyanato-κN)nickel(II), C46H36N6NiS2
- Crystal structure of sodium catena-poly[bis(thiourea-κ1S)-tetrakis(μ2-thiourea-κ2S,S)tricopper(I)] difumarate, C14H29Cu3N12NaO8S6
- Crystal structure of bis(benzylamine-κ1N)-bis((E)-2-methyl-3-phenylacrylato-κ1O)copper(II), C34H36CuN2O4
- The crystal structure of 3,4-dihydroxybenzoic acid – 3-[7-{[2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3] triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol – water (1/1/1), C30H36F2N6O9S
- Crystal structure of catena-poly[dipyridine-bis(pyridine-2-carboxylato-κ 2 N,O)-bis(μ 2-pyridine-2-carboxylato-κ 2 N,O)-dinickel(II)], C34H26N6Ni2O8
- The crystal structure of 1-((1-methyl-1H-1,2,4-triazol-3-yl) methyl)-3-(2,4,5-trifluorobenzyl)-1,3,5-triazinane-2,4,6-trione, C14H11F3N6O3
- Crystal structure of (E)-2-((Z)-2-((1S,4R)-3,3-dimethylbicyclo[2.2.1] heptan-2-ylidene)ethylidene)hydrazine-1-carbothioamide, C24H38N6S2
- Crystal structure of photochromic 3-(5-(2,5-dimethylthiophen-3-yl)-2,2,3,3,4,4-hexafluorocyclopentyl)-2-methylbenzo[b]-thiophene, C20H14F6S2
- Crystal structure of bis(2,5,5,7-tetramethyl-1,4-diazepane-1,4-diium) diaqua-bis(1,2-diaminopropane)copper(II) bis(μ6-oxido)tetrakis(μ3-oxido)-tetradecakis(μ2-oxido)-octaoxido-decavanadium(V) – water (1/4), C24H76CuN8V10O34
- Crystal structure of 1,2,3,5,13-pentamethoxy-6,7-dimethyl-1,2,3,4,4a,5,6,7,8,13b-decahydrobenzo[3′,4′]cycloocta[1′,2′:4,5]benzo[1,2-d][1,3]dioxole, C24H30O7
- Crystal structure of bis(6-carboxyhexyl)-4,4′-bipyridinium dibromide – 2,6-dihydroxynaphthalene (1/2), C42H46Br2N2O8
- Crystal structure of methyl 2-(2-chloroacetyl)-1-(4-(methoxycarbonyl)phenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b] indole-3-carboxylate, C23H21ClN2O5
- Crystal structure of bis(dimethylammonium) poly[{μ4-1,1ʹ-(1,4-phenylenebis(methylene))bis(1H-pyrazole-3,5-dicarboxylato)-κ6N4O2}zinc(II)], C22H26N6O8Zn
- Crystal structure of 2-(2-(4-methoxyphenyl)-2H-indazol-3-yl)acetonitrile, C16H13N3O
- Crystal structure of (E)-7-methoxy-2-(4-morpholinobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H23NO3
- The crystal structure of N′1,N′2-bis((E)-3-(tert-butyl)-2-hydroxybenzylidene)oxalohydrazide, C24H30N4O4
- The crystal structure of trimethyl 2,2′,2′′-(benzene-1,3,5-triyltris(oxy))triacetate, C15H18O9
- Crystal structure of bis(N,N-dimethylformamide-κO)-bis(pyridine-2-carboxylato-κ2N,O)-bis(μ2-pyridine-2-carboxylato-κ2N,O)-dinickel(II), C30H30N6Ni2O10
- Crystal structure of bis(μ2-1-pyrenecarboxylato-κ3O,O′:O′)-bis(1-pyrenecarboxylato-κ2O,O′)-(benzimidazole-κ1N)dicadmium(II), C82H48Cd2N4O8
- One-pot synthesis and crystal structure of diethyl 2,6-dimethyl-4-(1-(2-nitrophenyl)-1H-1,2,3-triazol-4-yl)-1,4-dihydropyridine-3,5-dicarboxylate, C21H23N5O6
- The crystal structure of 1-(2-fluorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-carbonitrile, C18H13FN2O2
- Crystal structure of bis(trimethylphenylammonium) aqua-oxido-octathiotritungstate, (Me3PhN)2[W3OS8(H2O)]
- The crystal structure of trichlorido[N-[(2-oxyphenyl)methylidene]phenylglycinemethylester-κ3O,N,O′]-tin(IV) – methylene chloride (1/1), C16H14Cl3NO3Sn·CH2Cl2
- The crystal structure of furan-2,5-diylbis((4-chlorophenyl)methanol), C18H14Cl2O3
- The crystal structure of hexalithium decavanadate hexadecahydrate, H32Li6O44V10
- Crystal structure of ethyl 4-{[5-(adamantan-1-yl)-2-sulfanylidene-2,3-dihydro-1,3,4-oxadiazol-3-yl]methyl}piperazine-1-carboxylate, C20H30N4O3S
- Crystal structure of aqua(μ2-2,2′,2″-((nitrilo)tris(ethane-2,1-diyl(nitrilo)methylylidene))tris (6-ethoxyphenolato))(pentane-2,4-dionato-κ2O,O′)-dinickel(II), C38H48N4Ni2O9
Articles in the same Issue
- Frontmatter
- New Crystal Structures
- The crystal structure of methyl 2-((4-chloro-2-fluoro-6-((2,2,2-trifluoroethyl) thio)phenoxy)methyl)benzoate, C17H13ClF4O3S
- The crystal structure of 3-hydroxy-5-oxo-4-propanoylcyclohex-3-ene-1-carboxylic monohydrate, C10H14O6
- Crystal structure of 2-({[5-(adamantan-2-yl)-2-sulfanylidene-1,3,4-oxadiazolidin-3-yl]methyl}amino)benzonitrile, C20H22N4OS
- Crystal structure of 1-(3-bromopropyl)-2-((4-chlorophenoxy)methyl)-4-methyl-1H-benzo[d]imidazole, C18H18BrClN2O
- Crystal structure of 2-methoxy-6-[(2-morpholin-4-yl-phenylamino)-methylene]-4-nitro-cyclohexa-2,4-dienone, C18H19N3O5
- The crystal structure of 2-(7-(2,3-dimethoxyphenyl)-[1,2,4]triazolo[1,5-a]-pyrimidin-5-yl)-3-methoxyphenol, C20H18N4O4
- The crystal structure of 3-(1-(2-(4-hydroxy-3,5-dimethoxybenzylidene)hydrazinyl)ethylidene)chroman-2,4-dione dihydrate, C20H22N2O8
- Crystal structure of 3,5,7-trimethoxy-3′,4′-methylenedioxy-flavone, C19H16O7
- The crystal structure of strictic acid, C20H26O3
- Crystal structure of 1,1′-(pyrazine-1,4-diyl)-bis(propan-2-one), C10H14N2O2
- The crystal structure of 1-(adamantan-1-yl)-3-(4-chlorophenyl)urea, C17H21ClN2O
- The crystal structure of (2R,6′R)-2′,7-dichloro-4,6-dimethoxy-6′-methyl-3H-spiro[benzofuran-2,1′-cyclohexan]-2′-ene-3,4′-dione, C16H14Cl2O5
- Synthesis and crystal structure of 1-((3R,10S,13R,17S)-3-((4-methoxyphenyl)amino)-10,13-dimethylhexadecahydro-1H-cyclopenta[α]-phenanthren-17-yl)ethan-1-one, C28H41NO2
- Crystal structure of N-2,6-difluorobenzoyl-N′-[1-(3-chloro-4-methyl-phenyl)-4-cyano-1H-pyrazol-5-carbamoyl]urea, C19H12ClF2N5O2
- Crystal structure of (−)-β-D-19-glucopiranosyl-9,15-dihydroxy kaurenoate, C26H40O9
- Crystal structure of 7-hydroxy-6-(2-hydroxyethyl)-2H-chromen-2-one, C11H10O4
- Crystal structure of S-(benzo[d]thiazol-2-yl)-N-(tert-butyl)thiohydroxylamine, C11H14N2S2
- Crystal structure of poly[di-µ2-aqua-aqua-nitrato-κ2O,O′-(µ3-2-nitroisophthalato-κ4O,O′:O″:O′″)barium(II)natrium(II)] monohydrate, C8H11BaN2NaO13
- The crystal structure of diaqua-bis(pyrazolo[1,5-a]pyrimidine-3-carboxylato-κ2 N,O)-cobalt(II) dihydrate, C14H16N6O8Co
- Crystal structure of (S,E)-3-((pyridin-2-ylmethylene)amino)-2-(pyridin-4-yl)-2,3- dihydroquinazolin-4(1H)-one monohydrate, C19H15N5O⋅H2O
- Synthesis and crystal structure of 5-(8-(((5-carboxypentyl)ammonio)methyl)-7-hydroxy-4-oxo-4H-chromen-3-yl)-2-hydroxy-3-nitrobenzenesulfonate monohydrate, C22H24N2O12S
- Synthesis and crystal structure of 8-bromo-3-(1H-pyrazole-1-carbonyl)-2H-chromen-2-one, C13H7BrN2O3
- Crystal structure of E-7-fluoro-2-(4-methoxy-3-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C19H14F4O2
- Hydrogen bonded dimers in the crystal structure of 2-chloro-N-((3,5-dimethylphenyl)carbamoyl)-nicotinamide, C30H28Cl2N6O4
- Crystal structure of 3,3′-(1,4-phenylenebis(methylene))bis(1-allyl-1H-imidazol-3-ium) bis(hexafluoro phosphate)(V), C10H12F6N2P
- Crystal structure of (E)-7-bromo-2-(4-(4-methylpiperazin-1-yl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H23BrN2O
- Crystal structure of pentacarbonyl-(μ2-ethane-1,2-dithiolato-κ4S:S,S′:S′)-(diphenyl(o-tolyl)phosphine-κ1P)diiron (Fe–Fe), C26H21Fe2O5PS2
- Crystal structure of 9-(2-chloroethoxy)-4-(4-methoxy-3-(trifluoromethyl)phenyl)- 5,6-dihydrobenzo[h]quinazolin-2-amine, C22H19ClF3N3O2
- Crystal structure of triaqua-[5-bromo-2-(carboxylatomethoxy)benzoate-κ3 O,O′,O″]nickel(II), C9H11BrNiO8
- The crystal structure of 4,4′-dichloro-3,5′-diphenyl-1′H-1,3′- bipyrazole, C18H12Cl2N4
- The crystal structure of bis(1H-pyrazole-carboxamidine-κN,N′)bis(nitrato-κO)-copper(II), C8H12CuN10O6
- Synthesis and crystal structure of 3-bromo-4-phenyl-2H-chromene, C15H11BrO
- Crystal structure of (E)-5-(diethylamino)-2-((morpholinoimino)methyl)phenol, C15H23N3O2
- Crystal structure of niobium trigallide, NbGa3
- Crystal structure of dimethyl 4,4′-(((1R, 2R)-cyclohexane-1,2-diyl)bis(azanediyl))dibenzoate, C22H26N2O4
- Crystal structure of dimethyl 4,4′-((4R, 5R)-4,5-diphenylimidazolidine-1,3-diyl)dibenzoate, C31H28N2O4
- The crystal structure of 2-(2-bromophenyl)-4-phenylbenzo[b][1,4]oxaphosphinine 4-oxide, C20H14BrO2P
- The crystal structure of 3-hydroxy-2-nitroestra-1,3,5(10)-trien-17-one, C18H21NO4
- Crystal structure of catena-poly[[μ2-1,3-bis[(1H-imidazol-1- yl)methyl]benzene-N:N′]-(μ2–D–camphorato-O, O′: O″, O‴)cadmium(II)], C48H56Cd2N8O8
- Crystal structure of N-(4-bromophenyl)-4-[3-(trifluoromethyl)phenyl]-piperazine-1-carbothioamide, C18H17BrF3N3S
- The crystal structure of cis-Dicyano-bis(2,2′-bipyridine)k2N,N′-chromium(III) hexafluorophosphate, C22H16N6F6PCr
- Crystal structure of 4-((6-bromohexyl)oxy)-2-hydroxybenzaldehyde, C13H17BrO3
- Crystal structure of hydrazinium methanesulfonate, CH8N2O3S
- Crystal structure of 1-(2-iodobenzoyl)-6-methoxy-1H-indole-3-carbaldehyde, C17H12INO3
- Crystal structure of bis(acridinium) tetrabromidomanganate(II), C26H20Br4MnN2
- The crystal structure of 6,6′-((1E,1′E)-hydrazine-1,2-diylidenebis(methanylylidene)) bis(2-(tert-butyl)phenol), C22H28N2O2
- The crystal structure of the cocrystal di-μ2-chlorido-tetramethyl-tetraphenyl-di-μ3-oxido-dichloridotetratin(IV) – diphenyl-methyl-chloridotin(IV)(1/2), C54H58Cl6O2Sn6
- Crystal structure of (3a7R,13bR)-3-((1R)-1-hydroxy-1-(5-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-3a,11,11,13b-tetramethyl-2,3,3a,4,5,11,11a,12,13,13b-decahydroindeno[5′,4′:4,5] cyclohepta[1,2-c]oxepin-9(1H)-one, C30H40O5
- Crystal structure of 1-(4-methoxyphenyl)-2-phenoxyethan-1-one, C15H14O3
- Crystal structure of trans-tetrakis(3-phenylpyridine-κN)bis(thiocyanato-κN)nickel(II), C46H36N6NiS2
- Crystal structure of sodium catena-poly[bis(thiourea-κ1S)-tetrakis(μ2-thiourea-κ2S,S)tricopper(I)] difumarate, C14H29Cu3N12NaO8S6
- Crystal structure of bis(benzylamine-κ1N)-bis((E)-2-methyl-3-phenylacrylato-κ1O)copper(II), C34H36CuN2O4
- The crystal structure of 3,4-dihydroxybenzoic acid – 3-[7-{[2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3] triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol – water (1/1/1), C30H36F2N6O9S
- Crystal structure of catena-poly[dipyridine-bis(pyridine-2-carboxylato-κ 2 N,O)-bis(μ 2-pyridine-2-carboxylato-κ 2 N,O)-dinickel(II)], C34H26N6Ni2O8
- The crystal structure of 1-((1-methyl-1H-1,2,4-triazol-3-yl) methyl)-3-(2,4,5-trifluorobenzyl)-1,3,5-triazinane-2,4,6-trione, C14H11F3N6O3
- Crystal structure of (E)-2-((Z)-2-((1S,4R)-3,3-dimethylbicyclo[2.2.1] heptan-2-ylidene)ethylidene)hydrazine-1-carbothioamide, C24H38N6S2
- Crystal structure of photochromic 3-(5-(2,5-dimethylthiophen-3-yl)-2,2,3,3,4,4-hexafluorocyclopentyl)-2-methylbenzo[b]-thiophene, C20H14F6S2
- Crystal structure of bis(2,5,5,7-tetramethyl-1,4-diazepane-1,4-diium) diaqua-bis(1,2-diaminopropane)copper(II) bis(μ6-oxido)tetrakis(μ3-oxido)-tetradecakis(μ2-oxido)-octaoxido-decavanadium(V) – water (1/4), C24H76CuN8V10O34
- Crystal structure of 1,2,3,5,13-pentamethoxy-6,7-dimethyl-1,2,3,4,4a,5,6,7,8,13b-decahydrobenzo[3′,4′]cycloocta[1′,2′:4,5]benzo[1,2-d][1,3]dioxole, C24H30O7
- Crystal structure of bis(6-carboxyhexyl)-4,4′-bipyridinium dibromide – 2,6-dihydroxynaphthalene (1/2), C42H46Br2N2O8
- Crystal structure of methyl 2-(2-chloroacetyl)-1-(4-(methoxycarbonyl)phenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b] indole-3-carboxylate, C23H21ClN2O5
- Crystal structure of bis(dimethylammonium) poly[{μ4-1,1ʹ-(1,4-phenylenebis(methylene))bis(1H-pyrazole-3,5-dicarboxylato)-κ6N4O2}zinc(II)], C22H26N6O8Zn
- Crystal structure of 2-(2-(4-methoxyphenyl)-2H-indazol-3-yl)acetonitrile, C16H13N3O
- Crystal structure of (E)-7-methoxy-2-(4-morpholinobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H23NO3
- The crystal structure of N′1,N′2-bis((E)-3-(tert-butyl)-2-hydroxybenzylidene)oxalohydrazide, C24H30N4O4
- The crystal structure of trimethyl 2,2′,2′′-(benzene-1,3,5-triyltris(oxy))triacetate, C15H18O9
- Crystal structure of bis(N,N-dimethylformamide-κO)-bis(pyridine-2-carboxylato-κ2N,O)-bis(μ2-pyridine-2-carboxylato-κ2N,O)-dinickel(II), C30H30N6Ni2O10
- Crystal structure of bis(μ2-1-pyrenecarboxylato-κ3O,O′:O′)-bis(1-pyrenecarboxylato-κ2O,O′)-(benzimidazole-κ1N)dicadmium(II), C82H48Cd2N4O8
- One-pot synthesis and crystal structure of diethyl 2,6-dimethyl-4-(1-(2-nitrophenyl)-1H-1,2,3-triazol-4-yl)-1,4-dihydropyridine-3,5-dicarboxylate, C21H23N5O6
- The crystal structure of 1-(2-fluorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-carbonitrile, C18H13FN2O2
- Crystal structure of bis(trimethylphenylammonium) aqua-oxido-octathiotritungstate, (Me3PhN)2[W3OS8(H2O)]
- The crystal structure of trichlorido[N-[(2-oxyphenyl)methylidene]phenylglycinemethylester-κ3O,N,O′]-tin(IV) – methylene chloride (1/1), C16H14Cl3NO3Sn·CH2Cl2
- The crystal structure of furan-2,5-diylbis((4-chlorophenyl)methanol), C18H14Cl2O3
- The crystal structure of hexalithium decavanadate hexadecahydrate, H32Li6O44V10
- Crystal structure of ethyl 4-{[5-(adamantan-1-yl)-2-sulfanylidene-2,3-dihydro-1,3,4-oxadiazol-3-yl]methyl}piperazine-1-carboxylate, C20H30N4O3S
- Crystal structure of aqua(μ2-2,2′,2″-((nitrilo)tris(ethane-2,1-diyl(nitrilo)methylylidene))tris (6-ethoxyphenolato))(pentane-2,4-dionato-κ2O,O′)-dinickel(II), C38H48N4Ni2O9